[
  {
    "sentence": "Among the lymphoid models, the cell lines derived from multiple myeloma (U266, MM1.S, and MM1.R) presented higher IC50 values for eribulin (from 10.66 to 37.03 nM) (Figure 1A and Table S2).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the normal leukocytes, eribulin did not impact the cell viability, suggesting selectivity for malignant blood cells and a favorable therapeutic window (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As shown in Figure 1B, eribulin exhibited dose- and time-dependent cytotoxicity in all of the leukemia cells assessed.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the lymphoid models, the cell lines derived from multiple myeloma (U266, MM1.S, and MM1.R) presented higher IC50 values for eribulin (from 10.66 to 37.03 nM) (Figure 1A and Table S2).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the normal leukocytes, eribulin did not impact the cell viability, suggesting selectivity for malignant blood cells and a favorable therapeutic window (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As shown in Figure 1B, eribulin exhibited dose- and time-dependent cytotoxicity in all of the leukemia cells assessed.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Eribulin significantly induced concentration-dependent apoptosis in the leukemia cells, as observed by phosphatidylserine exposure (all p < 0.05, Figure 2), and it increased the subG1 cell populations (all p < 0.05, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Eribulin also induced cell cycle arrest at the G2/M phase for the NB4, NB-R2, OCI-AML3, and Jurkat cells and at the G0/G1 phase for MOLM-13 (all p < 0.05, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The morphological analyses revealed a high frequency of mitotic aberrations upon conducting the treatment with eribulin for 72 h (Figure 4), which corroborates the cell cycle-related findings.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Similarly, the long-term exposure to eribulin markedly decreased the autonomous clonal growth in the NB4, NB4-R2, MOLM-13, OCI-AML3, and Jurkat cells (all p < 0.05, Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The p values and cell lines are indicated in the graphs; * p < 0.05, *** p < 0.0001; ANOVA test and Bonferroni post-test.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The p values and cell lines are indicated in the graphs; * p < 0.05, ** p < 0.01, *** p < 0.001; ANOVA and Bonferroni post-test.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The 400× and 1000× magnification images are displayed.Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Eribulin significantly induced concentration-dependent apoptosis in the leukemia cells, as observed by phosphatidylserine exposure (all p < 0.05, Figure 2), and it increased the subG1 cell populations (all p < 0.05, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Eribulin also induced cell cycle arrest at the G2/M phase for the NB4, NB-R2, OCI-AML3, and Jurkat cells and at the G0/G1 phase for MOLM-13 (all p < 0.05, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The morphological analyses revealed a high frequency of mitotic aberrations upon conducting the treatment with eribulin for 72 h (Figure 4), which corroborates the cell cycle-related findings.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Similarly, the long-term exposure to eribulin markedly decreased the autonomous clonal growth in the NB4, NB4-R2, MOLM-13, OCI-AML3, and Jurkat cells (all p < 0.05, Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Additionally, the eribulin exposure significantly induced γH2AX expression and PARP1 cleavage in all of the cell lines analyzed (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Additionally, the eribulin exposure significantly induced γH2AX expression and PARP1 cleavage in all of the cell lines analyzed (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "First, we determined the expression of the genes encoding the transmembrane drug efflux pump (ABCB1 and ABCC1), which encodes tubulin beta 3 class III (TUBB3) and STMN1 (Figure 7A) and the markers PI3K/AKT and NFkB-mediated signaling pathway expression and activation (Figure 7B,C).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Among these molecular targets, ABCB1 (r = 0.53, p = 0.02), ABCC1 (r = 0.67, p = 0.001), p-AKT (r = 0.53, p = 0.02), p-NFκB (r = 0.80, p < 0.0001), and NFκB (r = 0.81, p < 0.0001) were associated with IC50 values for eribulin in the blood cancer cell lines (Figure 7D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel D",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel D",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on these data, we constructed a resistance eribulin-related target (RERT) score that precisely predicted the sensitivity of the drug in the cellular models evaluated (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  }
]